LBA-03Efficacy and safety of regorafenib versus placebo in patients with hepatocellular carcinoma (HCC) progressing on sorafenib: results of the international, randomized phase 3 RESORCE trial
暂无分享，去创建一个
M. Kudo | J. Bruix | O. Yokosuka | G. Bodoky | G. Meinhardt | Yi‐Hsiang Huang | A. Granito | G. Han | G. Masi | S. Qin | O. Rosmorduc | T. Song | R. Gérolami | P. Merle | M. Leberre | V. Breder | J. Bronowicki | I. Ollivier-Hourmand | A. Baumhauer | P. Merle | J. Paul | György Bodoky | Y-H. Huang